The following resources are provided to assist clinicians considering providing doxycycline post-exposure prophylaxis (Doxy PEP) to their patients.

CDC Response to Doxy-PEP data presented at 2022 International AIDS Conference | Newsroom | NCHHSTP | CDC

CDC Considerations for Doxy-PEP Use

NEJM. Article: Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections

Lancet Article: Post-exposure Prophylaxis with Doxycycline to Prevent Sexually Transmitted Infections in Men Who Have Sex with Men: an Open-Label Randomised Substudy of the ANRS IPERGAY Trial


Doxy-PEP Abstracts from CROI 2023 with Links to Presentations


Last Updated August 8, 2023